Search clinical trials for: brinzolamide 1%/brimonidine 0.2%

Total 479 results

Nottingham University Hospitals NHS Trust
University of Nottingham; Sonova AG

Completed

Evaluation of the eAdjust Application

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

United Kingdom
Alcon Research

Completed

A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%

Ocular Hypertension | Open-Angle Glaucoma
Technical University of Munich

Completed

Sugammadex and Neostigmine at Residual Neuromuscular Blockade (SUNDRO20)

Residual Neuromuscular Block (TOF-ratio of 0.2)

Germany
J P Lecoq

Completed

Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block.

Postoperative Complications | Postoperative Pain

Belgium
Teva Pharmaceuticals USA

Completed

Desmopressin Acetate 0.2 mg Tablets, Fasting

Healthy

Canada
City of Hope Medical Center

Active, not recruiting

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Prostate Adenocarcinoma

United States
Wannisa Suphachearabhan
Srinakharinwirot University

Completed

Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

Recurrent Pterygium of Eye | Steroid-Induced Glaucoma
Alcon Research

Completed

Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%

Ocular Hypertension | Open-Angle Glaucoma
Patagonia Pharmaceuticals, LLC

Completed

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Congenital Ichthyosis

United States
HistoSonics, Inc.

Withdrawn

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

Benign Prostatic Hyperplasia (BPH)
Novartis Pharmaceuticals

Completed

Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma

Glaucoma

Korea, Republic of
Kowa Company, Ltd.

Completed

A Phase III Long Term Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Dermavant Sciences GmbH

Completed

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Azienda Ospedaliero, Universitaria Meyer

Completed

Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)

Retinopathy of Prematurity

Italy
G. d'Annunzio University

Unknown

0.2% Chx Gel vs Implant Bacterial Contamination

Bone Resorption | Bacteria Caused Disease

Italy
University of Pennsylvania

Completed

Pulmonary Function and Interscalene Block

Shoulder Arthroscopy
United Christian Hospital

Unknown

Postoperative Patient Controlled Epidural Analgesia After Total Knee Arthroplasty With 2ug/ml Fentanyl Combine With 0.2% Ropivacaine or 0.2% Levobupivcaine

Arthroplasty, Replacement, Knee | Patient-controlled Analgesia

Hong Kong
Takeda

Completed

Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

Impaired Glucose Tolerance

Japan
Kowa Company, Ltd.

Completed

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
University Ramon Llull
Ainhoa Nieto Guisado; Mònica Solana-Tramunt

Unknown

The Effects of Cognitive-motor Training in Healthy Older Adults

Cognitive Change | Proprioception Change | Balance Change

Spain
Nobelpharma

Completed

NPC-12G Gel 0.2% Sirolimus PK Bridging Study

Bioavailability Study

United States
Alcon Research

Completed

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis
The Leeds Teaching Hospitals NHS Trust

Unknown

Chromoendoscopy in Inflammatory Bowel Disease

Colonoscopy

United Kingdom
University Health Network, Toronto

Unknown

PIB Versus CI Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle Surgery

Pain, Postoperative

Canada
Novartis Pharmaceuticals

Completed

A First-in-Human Study of CEE321 in Adult Subjects

Atopic Dermatitis

United States, Japan
Istituto Ganassini S.p.A. di Ricerche Biochimiche

Recruiting

Comparative Clinical Trial on Neoviderm Skin Emulsion and Connettivi-na 0.2% Cream to Evaluate the Normalization Process of the Skin and Re-duction of Cutaneous Tension and Pain in Patients With Superficial Burns Grade 1 and 2 (NVD01/22)

Dermatology

Italy
Edesa Biotech Inc.
JSS Medical Research Inc.

Active, not recruiting

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis

Allergic Contact Dermatitis

United States, Canada
Moberg Pharma AB

Completed

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (CIPT)

Erythema

United States
Research Insight LLC

Completed

Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization (CLEAN)

Dry Eye

United States
Shaperon

Recruiting

Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients

COVID-19 Pneumonia

Korea, Republic of
Royal Perth Hospital

Completed

Role of Sympathetic Activation in Ischemia Reperfusion Injury

Central Sympathetic Nervous System Diseases

Australia
ASST Gaetano Pini-CTO

Completed

Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus

Injury of Anterior Cruciate Ligament

Italy
Shaperon

Completed

Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients

COVID19 Pneumonia

Romania
University of Oslo

Unknown

Clinical Effect of Chlorhexidine Mouthwash After Periodontal Surgery

Periodontitis | Periodontal Diseases | Dental Plaque

Norway
Recep Tayyip Erdogan University

Completed

The Effect of Nitroglycerin Infusion Rate on Cerebral Rewarming During Hypothermic Coronary Artery Bypass Grafting (nitrotherm)

Coronary Artery Bypass | Cardiopulmonary Bypass

Turkey
Kwang Dong Pharmaceutical co., ltd.

Completed

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

Overactive Bladder

Korea, Republic of
Dermavant Sciences GmbH

Completed

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Atopic Dermatitis

Canada, United States
Georgetown University

Completed

Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging

Peripheral Vascular Disease

United States
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

Seasonal Allergic Rhinitis

United States
University Hospital, Rouen

Withdrawn

Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging (DRAGON)

Cardiac Graft

France
SIFI SpA

Completed

Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye

Dry Eye

Italy
Özlem SARAÇ ATAGÜN

Completed

Effects of Interdental Brush Dipped in 0.2% Hyaluronic Acid Gel on Periodontitis

Periodontitis

Turkey
Tatyasaheb Kore Dental College

Completed

Evaluation and Comparison of the Efficacy of Triphala Mouthwash and 0.2% Chlorhexidine

Periodontal Disease
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES) (EFIRTES)

Extrathoracic Sarcoidosis

France
GlaxoSmithKline

Completed

A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Dermatitis, Atopic

Germany
Thymon, LLC

Completed

Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects (THYMON-10001)

HIV Infections

United States
Ondokuz Mayıs University

Completed

THE EFFECT OF VIRTUAL REALITY ON CHILDREN'S ANXIETY, FEAR, AND PAIN LEVELS BEFORE CIRCUMCISION IN TURKEY

to Have a Circumcision Operation

Turkey
University of Medicine and Pharmacy at Ho Chi Minh...

Completed

Hyaluronic Acid 0.2% Application Enhanced Chronic Periodontitis Treatment in Non-surgical Phase

Chronic Periodontitis, Hyaluronic Acid

Vietnam
Joint Authority for Päijät-Häme Social and Health...
Helsinki University Central Hospital

Completed

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Actinic Keratoses

Finland

3

Subscribe